Brief: Biomed-Lublin Gets 43.2 Mln Zloty Subsidy For Onko BCG Production Plant
Sept 1(Reuters) - Biomed-Lublin Wytwórnia Surowic i
Szczepionek SA BML.WA :
* SAID ON TUESDAY IT HAS RECEIVED 43.2 MILLION ZLOTY NET
SUBSIDY
FOR CONSTRUCTION OF ONKO BCG PRODUCTION PLANT
* TOTAL INVESTMENT VALUE IS 71.9 MILLION ZLOTYS NET
* CONSTRUCTION IS PART OF PROJECT TO PRODUCE BLADDER CANCER
DRUG
* EXPECTS PROJECT COMPLETION IN Q4 2023
Source text for Eikon: urn:newsml:reuters.com:*:nEM1d9pwja
Further company coverage: BML.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility